Why the study?
Does dobutamine echocardiography improve the detection of viable myocardium in patients with ischemic cardiomyopathy?
Does dobutamine echocardiography improve the detection of viable myocardium in patients with ischemic cardiomyopathy?
This review highlights the established utility of dobutamine echocardiography for detecting viable myocardium to guide revascularization decisions in patients with ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May inform revascularization decisions in ischemic cardiomyopathy; reinforces consensus from Level 5 data but leaves open prospective outcome trials.
In patients with ischemic cardiomyopathy, revascularization of hibernating or stunned myocardium can result in improvement in global systolic function and prognosis. The recognition that revascularization can alter the course of ischemic cardiomyopathy has fueled the development of noninvasive methods for detection of viable myocardium. Dobutamine echocardiography has established utility as a method for identifying hibernating and stunned myocardium thereby improving the selection of candidates with ischemic cardiomyopathy for revascularization. This manuscript reviews the rationale and methodology for use of low and high dose dobutamine echocardiography for detection of viable myocardium. The predictive value of the technique is discussed and compared with that of other noninvasive imaging methods.
No takes yet. Share an insight, caveat, or question.
Stephen G. Sawada (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: